Novel GSK-3 inhibitor increases neuron survival and attenuates neuropathology in transgenic AD mice July 31, 2008
Advances in development of agents for neurological disorders documented in recent patents July 30, 2008
FDA issues not approvable letter to Eisai for sedative-hypnotic agent fospropofol disodium July 30, 2008
RSS